BSEInsider Trading / SAST4d ago · 12 Oct 2026, 05:38 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Essix Biosciences Ltd & Others
Ind-Swift Laboratories Ltd · 532305
✦ AI SummaryRelated Party
Ind-Swift Laboratories Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Essix Biosciences Ltd & Others.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ind-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011